These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8496821)

  • 1. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.
    Kadowaki M; Nagakura Y; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 Jul; 266(1):74-80. PubMed ID: 8331576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
    Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.
    Miyata K; Kamato T; Yamano M; Nishida A; Ito H; Katsuyama Y; Yuki H; Tsutsumi R; Ohta M; Takeda M
    J Pharmacol Exp Ther; 1991 Nov; 259(2):815-9. PubMed ID: 1941629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum.
    Tuladhar BR; Kaisar M; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1174-8. PubMed ID: 9401783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species difference in the 5-hydroxytryptamine3 receptor associated with the von Bezold-Jarisch reflex.
    Yamano M; Ito H; Kamato T; Miyata K
    Arch Int Pharmacodyn Ther; 1995; 330(2):177-89. PubMed ID: 8861711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
    Yamano M; Kamato T; Nishida A; Ito H; Yuki H; Tsutsumi R; Honda K; Miyata K
    Jpn J Pharmacol; 1994 Jul; 65(3):241-8. PubMed ID: 7799524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum.
    Tuladhar BR; Womack MD; Naylor RJ
    Br J Pharmacol; 2000 Dec; 131(8):1716-22. PubMed ID: 11139451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.
    Miyata K; Kamato T; Nishida A; Ito H; Katsuyama Y; Iwai A; Yuki H; Yamano M; Tsutsumi R; Ohta M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):15-21. PubMed ID: 1656016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective 5-hydroxytryptamine3 (5-HT3) receptor blocking activity of KB-R6933, a novel benzimidazole derivative.
    Ozaki A; Fujishima Y; Sukamoto T
    Jpn J Pharmacol; 1999 May; 80(1):25-32. PubMed ID: 10446753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of inhibitory effects of serotonin (5-HT)3-receptor antagonists, YM060 and YM114 (KAE-393), on the von Bezold-Jarisch reflex induced by 2-Methyl-5-HT, veratridine and electrical stimulation of vagus nerves in anesthetized rats.
    Yamano M; Ito H; Kamato T; Miyata K
    Jpn J Pharmacol; 1995 Dec; 69(4):351-6. PubMed ID: 8786638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCK-mediated response in the activation of 5-HT receptor types in the guinea-pig ileum.
    Fortuño A; Ballaz S; Del Río J; Barber A
    J Physiol Biochem; 1999 Jun; 55(2):85-92. PubMed ID: 10517265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitization as a discriminative tool for the 5-HT3 and putative 5-HT4 receptors in guinea pig ileum.
    Craig DA; Eglen RM; Walsh LK; Perkins LA; Whiting RL; Clarke DE
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):9-16. PubMed ID: 2402303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.
    Eglen RM; Lee CH; Smith WL; Johnson LG; Clark R; Whiting RL; Hegde SS
    Br J Pharmacol; 1995 Feb; 114(4):860-6. PubMed ID: 7773547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pinacidil suppression on 5-HT3 receptor-mediated contraction of guinea pig ileum in vitro.
    Yuan YM; Xu DY; Hu GY
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):31-5. PubMed ID: 10375754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets.
    Endo T; Ogawa T; Hamaue N; Akita K; Hirafuji M; Minami M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
    Yamano M; Kamato T; Miyata K
    Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.